Download - Ipertiroidismo - Terapia definitiva
IPERTIROIDISMO: TERAPIA DEFINITIVA.
COME E QUANDO
Michele Zini
Servizio di Endocrinologia - Arcispedale S. Maria Nuova, IRCCS Reggio Emilia
Definitive treatment
A definitive treatment of GD is recommended in case of:
• Occurrence of a major adverse reaction to ATDs or persistence of unpleasant minor side effects
• Unsatisfactory response to ATDs or poor compliance of the patient
• Coexisting morbidities that suggest a definitive control of thyroid hyperfunction
• Relapse of hyperthyroidism after withdrawal of medical treatment
• Pregnancy planning
Radioiodine therapy (RAI)
RAI is the most cost-effective treatment for GD and is followed in nearly all patients by a definitive cure of hyperthyroidism. Patients should be informed that in most cases this target is reached at the expense of hypothyroidism induction
Indications for 131I treatment are:• ATDs use contraindications• Presence of comorbidities that cause a high surgical risk• Previous thyroid surgery or external beam irradiation• Lack of an experienced thyroid surgeon
Radioiodine therapy (RAI)
Contraindications for RAI treatment are:
• Pregnancy and breast feeding• Very young age (< 5 years)• Presence of suspicious or malignant thyroid nodules• Severe active Graves orbitopathy (GO)
Surgical treatment
• When surgery is needed, total thyroidectomy should be performed as the procedure of choice
• Hyperthyroidism should be carefully controlled with MMI before thyroidectomy
Thyroidectomy should be considered in presence of:• Large goiter not suitable for RAI treatment • Diagnosis or suspect of thyroid malignancy• Need of hyperthyroidism resolution in the short-term
(pregnancy planned within 6 months)• Severe active GO
Surgical treatment
Surgery is contraindicated in:• First and third trimester of pregnancy• Patients at surgical risk due to relevant
comorbidities or previous thyroid surgery surgery
Fattori di rischio per ipoparatiroidismo postchirurgico Thomusch O. et al., Surgery 133: 180-185, 2003
Mic
he
le
Zin
i 2
01
0
CONCLUSIONS: Extent of resection and surgical technique had a greater impact on permanent postoperative hypoparathyroidism than thyroid pathologic condition.
CHIRURGIA RADIOIODIO
ETA’ RIDOTTA
NODULARITA’ AVANZATA
ETA’ AVANZATA
NODULARITA’ RIDOTTA
CONCLUSIONI (1)
• Pazienti stabilmente eutiroidei con basse dosi di metimazolo possono proseguire in sicurezza la terapia per un tempo indefinito
• Per molti pazienti potrebbe essere preferibile mantenere uno steady state con i farmaci rispetto al cambio di strategia che comportano i trattamenti definitivi
CONCLUSIONI (2)
• Prima di passare ad un trattamento definitivo:• il corso di terapia con metimazolo deve
essere di durata sufficientemente lunga per rendere ragionevolmente improbabile che il m. di Basedow vada in remissione
• ogni volta che è possibile, si deve tentare la sospensione della terapia
CONCLUSIONI (3)
Se si decide per un trattamento definitivo:• informare il paziente sul carattere
irreversibile del trattamento ablativo
• informare il paziente sul probabile sviluppo di ipotiroidismo
CONCLUSIONI (4)
Nel decidere sul tipo di trattamento definitivo:• valutare il rischio anestesiologico• valutare l’aspetto ecografico della
tiroide• tenere nella dovuta considerazione i
values del paziente